Company Search:
Advanced Search
Sponsored Links
Beijing Tiantan Biologic. Company Snapshot
Beijing Tiantan Biologic. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Tiantan Biologic. with three other companies in this sector in China: China Biologic Products Holdings Inc (2018 sales of 3.09 billion Chinese Renmimbi [US$449.04 million] of which 32% was Human Albumin), Tonghua Dongbao Medicines Company Limited (2.69 billion Chinese Renmimbi [US$390.42 million] of which 87% was Pharmaceutical), and Hualan Biological Engineering Inc (3.22 billion Chinese Renmimbi [US$467.29 million] of which 75% was Blood Product).

Sales Analysis. Beijing Tiantan Biologic. reported sales of 2.93 billion Chinese Renmimbi (US$425.76 million) for the year ending December of 2018. This represents an increase of 66.0% versus 2017, when the company's sales were 1.77 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Beijing Tiantan Biologic.
  Stock Performance Chart for Beijing Tiantan Biologic.
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 27.80
(Figures in Chinese Renmimbi)
1 Week -0.2%   13 Weeks 2.3%  
4 Weeks -7.0%   52 Weeks 72.5%  
Beijing Tiantan Biologic. Key Data:
  Ticker: 600161 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 2,931,047,025
(Year Ending Jan 2019).
Employees: 3,195
  Currency: Chinese Renmimbi Market Cap: 29,061,197,235
  Fiscal Yr Ends: December Shares Outstanding: 1,045,366,807
  Share Type: A Gu Closely Held Shares: 694,891,982
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.